TACHOSIL, matrix for collage tissulaire CIP 3400956580811
Active ingredients: FIBRINOGÈNE HUMAIN, Thrombin
Commercialized according to BDPMDispensing in France: Prescription only, hospital use
MatrixCIP 3400956580811intralésionnelle
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- TACHOSIL, matrice pour collage tissulaire
- Pharmaceutical form
- matrice
- Route of administration
- intralésionnelle
- Presentation description
- plaquette(s) PET-GAG (polyéthylène téréphtalate - glucosaminoglycane) polyéthylène de 2 éponge(s) de 4,8 cm x 4,8 cm
- Marketing authorisation holder
- CORZA MEDICAL (ALLEMAGNE)
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 24 Oct 2005
- Prescription and dispensing conditions
- Prescription only, hospital use
- List I: prescription-only medicine
- Hospital use only
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
61695844CIP75658081CIP133400956580811Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| FIBRINOGÈNE HUMAINmatrice | 5,5 mg · 1 cm^2 | SA |
| THROMBINE HUMAINEmatrice | 2 UI · 1 cm^2 | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.